Home/Filings/4/0000950170-24-134522
4//SEC Filing

WINDSOR JAMES BRIAN 4

Accession 0000950170-24-134522

CIK 0001420565other

Filed

Dec 8, 7:00 PM ET

Accepted

Dec 9, 4:09 PM ET

Size

7.7 KB

Accession

0000950170-24-134522

Insider Transaction Report

Form 4
Period: 2024-12-05
WINDSOR JAMES BRIAN
President and COO
Transactions
  • Purchase

    Common Stock

    2024-12-05$2.24/sh+239$535239 total(indirect: By son)
  • Purchase

    Common Stock

    2024-12-05$2.25/sh+161$362161 total(indirect: By son)
Holdings
  • Common Stock

    7,122
  • Common Stock

    (indirect: By son)
    225
Footnotes (1)
  • [F1]The reporting person disclaims beneficial ownership of all securities held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Documents

1 file

Issuer

Aileron Therapeutics, Inc.

CIK 0001420565

Entity typeother

Related Parties

1
  • filerCIK 0001790933

Filing Metadata

Form type
4
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 4:09 PM ET
Size
7.7 KB